BIOTIME INC → OncoCyte Corp IMDX

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

1 transaction

1 buys · 0 sales · 0 awards/exercises

Issuer Cluster

2 13D/G filings on this issuer

1 other filing besides this one

Filer Track Record

1 filings by this filer

0 other filings in the data moat

Short Interest · settle 2026-03-31

DTC 1.25

368,283 shares short · +99.4% vs prior

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-04-23	BROADWOOD PARTNERS, L.P.	10%+ owner	Buy	280,381	$3.50	$982K

Other 13D/G Filings on OncoCyte Corp

Filed	Form	Filer	Stake	Shares
2025-02-10	SCHEDULE	BROADWOOD PARTNERS, L.P.	40.20%	11,560,350	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →